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Abstract  
Purpose  
To assess the proportion of the association between obesity and diabetes mediated by liver enzymes such 
as gamma-glutamyltransferase (GGT), alanine transaminase (ALT) and aspartate transaminase (AST).  
Methods 
Mediation analysis was used with adjustment for age, education, physical activity, smoking and alcohol 
use.  
Results  
9,748 participants from Phase 3 of the Guangzhou Biobank Cohort Study were recruited in 2006-2008. 
For women, the association of BMI and WC with glucose was partially mediated by GGT, 30% (95% 
confidence interval 23% to 40%) and 28% (23% to 34%), and by ALT, 15% (14% to 25%) and 14% (10% 
to 18%), respectively; for men, .the proportion mediated by GGT was 16% (9% to 26%) and 23% (12% 
to 36%) respectively, and by ALT 12% (4% to 22%) for BMI and for WC. The association of BMI and 
WC with glucose was not mediated by AST for women or men. Additionally considering of mediation by 
lipids did not change the mediation by GGT and ALT. 
Conclusion  
The effect of obesity on diabetes is partly mediated by GGT and ALT but not AST. There is no evidence 
of the mediation effect by lipids. Our results may provide opportunities to identify new targets for 
diabetes interventions. (200 words) 
  
Introduction  
The risk of diabetes is increased by obesity [1, 2] and poor liver function.[3]Weight loss improves liver 
function in obese individuals.[4]So, obesity may cause diabetes, via an impact on liver function. Little 
assessment has been made of the contribution of obesity to diabetes mediated through liver function. 
Traditional regression modeling is limited in identifying mediation. We took advantage of the recent 
improvement in structural equation modeling [5, 6] to estimate the risk of diabetes attributable to obesity 
mediated through poor liver function. Although this evidence is necessarily circumstantial, such an 
approach can still provide important support and motivation for more definitive investigations. 
 
Mediation analysis allows researchers to identify mechanisms by which a treatment or exposure 
influences an outcome of interest, can provide evidence for the causal pathways by which obesity operate, 
and can be recommended as a method of improving the design and effectiveness of future diabetes 
prevention and interventions. As such, and given the high prevalence of diabetes in the world,[7] 
investigating the modifiable mediators of obesity that can be targeted may allow further effective control. 
 
Methods 
The Guangzhou Biobank Cohort Study (GBCS) is a study of lifestyle and genetic factors on health. 
Details of GBCS have been reported previously.[8]Briefly, GBCS is a 3-way collaboration of the 
Guangzhou 12
th
 Hospital and the Universities of Hong Kong and Birmingham, UK. Participants were 
recruited in three phases from the “Guangzhou Health and Happiness Association for the Respectable 
Elders” (GHHARE), a community social and welfare organization. Membership is open to Guangzhou 
permanent residents aged 50 years or above for a nominal fee of 4 CNY (about 50 US cents) per month. 
GHHARE included about 7% of Guangzhou residents in this age group, with branches in all 10 districts 
of Guangzhou, the capital city of Guangdong province in southern China. Within sex and age group, the 
participants had fairly similar levels of chronic diseases such as diabetes and hypertension to nationally 
representative samples of urban Chinese.[8] 
 Physical examination included an interview concerning lifestyle, family and personal medical history and 
assessment of weight, height, waist circumference, blood pressure, fasting plasma glucose and lipids. 
Information on socioeconomic position and lifestyle including age, sex, education, smoking and alcohol 
use was collected by a standardized questionnaire. Physical activity was assessed using a validated 
Chinese version of the International Physical Activity Questionnaire.[9]Anthropometric measurements 
were performed by trained nurses in the Guangzhou 12
th
 Hospital using standard protocols. Participants 
wore light clothing and no shoes. Body weight was measured to the nearest 0.1 kilogram using a balance 
beam scale (RGZ-120-RT, China). Waist circumference (WC) was measured horizontally around the 
smallest circumference between ribs and iliac crest, or at the navel, if there was no natural waistline. Body 
mass index (BMI) was calculated using measured weight and height as weight in kilograms divided by 
height in meters squared. Plasma glucose, lipids and liver enzymes (phase 3 only) were measured by 
Shimadzu CL-8000 Clinical Chemistry Analyzer (Shimadzu, Kyoto, Japan). The Guangzhou Medical 
Ethics Committee of the Chinese Medical Association approved the study and all participants gave 
written, informed consent before participation.  
 
Statistical analysis  
Pearson chi-square test and one-way analysis of variance were used to compare demographic and clinical 
characteristics by sex. We assessed whether the associations of BMI/WC with liver enzymes or diabetes 
varied by sex. BMI and WC were considered as exposures, liver enzymes including GGT, ALT and AST 
as potential mediators, and fasting plasma glucose as the study outcome. To assess the causal mediation 
effects, we used the potential outcomes framework. Let Mi(e) denote the potential values of the mediator 
for unit i under the exposure status (Ei=e), and Yi(e, m) denote the potential outcome for unit i when Ei=e 
and Mi=m. Thus the observed variables can be written as Mi=Mi(Ei) and Yi=Yi(Ei, Mi(Ei)). The causal 
mediation effect (𝛿𝑖(𝑒)) for unit i under exposure level e can be obtained as 𝛿𝑖(𝑒) ≡ 𝑌𝑖(e, 𝑀𝑖(1)) − 𝑌𝑖(e,
𝑀𝑖(0)). In this equation, the total effect can be expressed as 𝛿𝑖(1) and the non-mediated effect as 𝛿𝑖(0). 
The average casual mediation effect was thus calculated as 𝛿?̅?(𝑒) ≡ 𝔼(𝛿𝑖(𝑒)) ≡ 𝔼{𝑌𝑖(e, 𝑀𝑖(1)) −
𝑌𝑖(e, 𝑀𝑖(0))}. [5, 6] Causal mediation analysis based on linear regression with a nonparametric bootstrap 
(i.e., 500 resamples) was conducted using R Mediation package [10]to obtain the adjusted associations of 
BMI/WC with liver enzymes, the adjusted associations of liver enzymes with fasting glucose, the 
adjusted association of BMI/WC with fasting glucose and the proportion mediated by liver enzymes. We 
also assessed if the association of BMI/WC with diabetes varied with liver enzymes. To facilitate 
comparison between liver enzymes, z-scores (standard deviations (SD)) of BMI, WC and log-transformed 
GGT, ALT and AST were used for data analysis. As both obesity and liver function may vary with age, 
socioeconomic position, smoking,[11]alcohol use[12, 13] and physical activity[14]; these were included 
as potential confounders. Given the association of obesity with liver enzymes might vary by sex, we 
assessed whether the association varied by sex from the heterogeneity across strata and the significance of 
interaction terms in a model which included potentially confounding interactions. As a sensitivity analysis 
we also considered multiple mediation and whether any associations were mediated by lipids. Statistical 
analyses were performed using R Studio (version 0.98.976) and specifically the “mediation” package for 
the mediation analysis and STATA/IC 10.1 (Stata Corp LP, College Station, TX, USA). 
 
Results  
A total of 9,748 participants recruited for the Phase 3 of the Guangzhou Biobank Cohort Study (GBCS) 
from September 2006 to January 2008 were included in the current study. Table 1 shows that men were 
older and had higher education, while women were more physically active and less likely to be alcohol 
drinkers or smokers. Men had higher WC and higher liver enzymes (GGT, ALT and AST), lower high- 
and low-density lipoprotein cholesterol but comparable BMI, triglycerides and fasting glucose to women.  
 
As the association of obesity indices with liver enzymes varied by sex (p values for interaction <0.01), 
mediation analysis was conducted in women and men separately. In women, after adjustment for age, 
education, physical activity, smoking and alcohol use, the associations of BMI and WC with fasting 
glucose were significantly mediated by GGT and ALT. In women, the proportion of the associations of 
BMI and WC with fasting glucose mediated by GGT was 30% (95% confidence interval (CI) 23% to 
40%) and 28% (95% CI 23% to 34%), and mediated by ALT was 15% (95% CI 14% to 25%) and 14% 
(95% CI 10% to 18%), respectively. In men, the proportion of the associations of BMI and WC with 
fasting glucose mediated by GGT was lower than for women after similar adjustment (16% (95% CI 9% 
to 26%) and 23% (95% CI 12% to 36%), respectively). The same proportion of the associations of BMI 
and WC with glucose was mediated by ALT (both 12% (95% CI 4% to 22%). No mediation by AST was 
found for women or men.  
 
Considering GGT as a main mediator and simultaneously taking into account ALT as an alternative 
mediator, compared with the model with single mediator, the mediation effect was reduced but remain 
statistically significant, and the regression coefficient decreased from 0.05 (95% CI 0.04 to 0.07) (Table 2) 
to 0.04 (95% CI 0.02 to 0.06) (Table not shown) for women, and from 0.04 (0.02 to 0.06) (Table 2) to 
0.02 (-0.003 to 0.05) (Table not shown) for men. Additionally considering multiple mediation effect by 
including lipids such as triglycerides, and high- and low-density lipoprotein cholesterol in the causal 
mediation models did not reduce the average causal mediation effect by GGT and ALT. (Table not shown) 
 
Discussion  
The current study aimed to determine the degree to which liver enzymes, such as GGT, ALT and AST, 
mediate the known effect of obesity on glucose. We found that GGT most clearly mediated the effects of 
BMI/WC on fasting glucose, followed by ALT. As expected, AST did not mediate the effect of obesity 
on glucose. Mediation by GGT and ALT was greater in women than men. Questions about the effect of 
obesity on diabetes or of liver function on diabetes are not new; however, here we provide for the first 
time an assessment of the extent to which these effects of obesity on glucose are mediated by liver 
enzymes based on a large community-based study and suggest a further target for diabetes prevention or 
intervention.  
 
A recent study showed that obesity was associated with liver-specific increase of DNA methylation 
probably by increasing oxidative stress and metabolic pressure.[15]The authors suggest that obesity may 
increase the age of liver tissue and lead to liver-related comorbidities of obesity, such as insulin resistance 
and diabetes. Previous epidemiological studies have also reported an association of obesity and liver 
function with diabetes,[16, 17]but did not formally test mediation. We found that both GGT and ALT 
partially mediated the effect of BMI/WC on glucose, which may be more relevant at a population than an 
individual level. Given the mediation was partial, obesity may also have a direct effect on diabetes or an 
effect via other possible mediators.  
 
In our study men had stronger BMI-ALT/GGT association than women (all P for sex interaction <0.01). 
The possible explanation of this finding is that women tend to have a higher proportion of body fat stored 
in subcutaneous regions while men tend to have more visceral fat.[18, 19] At the same BMI men may 
have a higher percentage of visceral fat than women,[18] which may lead to a higher risk for poor liver 
function.[20]Thus the statistical analysis was conducted separately by sex. Moreover, statistically, liver 
enzymes were considered as mediators rather than confounders because the causal association of 
adiposity with liver enzymes including ALT and GGT,[2] and the causal association of GGT with insulin 
resistance is supported by a recent study using Mendelian randomization approach.[3] The statistical 
method used in our study thus enabled us to provide more straightforward and robust estimate of the 
mediation effect,   
 
The strengths of our study include the large sample size, the standardized assessments and the novelty of 
the analytic approach. However, there are some limitations of the current study. First, our models were 
based on measures of obesity indices and liver enzymes from a single point in time which might not 
reflect risk associated with lifetime exposure to obesity or changes in liver enzymes over time. 
Measurement errors could attenuate the estimates of the mediation. Despite this, mediation by GGT and 
ALT were from moderate to low. Second, some of the effects of obesity is likely mediated by 
inflammation,[21]perhaps by C-reactive protein[22]or interleukin-6,[23] which were not available in our 
study. Further studies are warranted to evaluate mediation effect by inflammation markers. In addition, 
although BMI and WC are widely used for epidemiological studies, these obesity indices are somewhat 
suboptimal measures of adiposity because BMI is correlated both with obesity and muscle mass and both 
BMI and WC are of great inter-ethnic variability.[24, 25] 
 
Conclusions 
 
The effect of obesity on diabetes was partly mediated by GGT and ALT but not by AST. There is no 
evidence of the mediation effect due to lipids. This study re-emphasizes the importance of liver function 
for diabetes prevention and intervention, and offer opportunities to identify new target for diabetes 
interventions.  
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Table 1: Demographic characteristics of the participants  
 
 Women (n=7,274) Men (n=2,474) P-value  
Age, years, mean (SD)  59.7 (7.6) 63.6 (7.6) <0.001 
Education, %     
Primary or below 41.0 28.7 <0.001 
Middle school  52.8 56.4  
College or above  6.2 14.9  
Physical activity, %    
Inactive  8.4 9.0 <0.001 
Moderate   25.0 34.1  
Active   66.6 56.9  
Alcohol use, %    
Never   59.2 38.9 <0.001 
Former    4.9 6.6  
Current   35.9 54.6  
Smoking, %    
Never   97.3 37.3 <0.001 
Former    1.3 26.9  
Current   1.5 35.7  
Body mass index, kg/m
2
, mean (SD) 23.9 (3.4) 23.5 (3.2) <0.001 
Waist circumference, cm, mean (SD) 77.0 (8.9) 81.0 (9.2) <0.001 
HDL-cholesterol, mmol/l, mean (SD) 1.7 (0.4) 1.5 (0.4) <0.001 
LDL-cholesterol, mmol/l, mean (SD) 3.5 (0.7) 3.2 (0.7) <0.001 
Triglycerides, mmol/l, geometric mean (95% CI) 1.51 (1.5-1.53) 1.52 (1.49-1.56) 0.64 
Log-GGT, u/l, mean (SD) 3.03 (0.56) 3.32 (0.58) <0.001 
Log-ALT, u/l, mean (SD) 3.06 (0.50) 3.15 (0.50) <0.001 
Log-AST, u/l, mean (SD) 3.23 (0.32) 3.28 (0.32) <0.001 
Fasting glucose, mmol/l, mean (SD) 5.7 (1.6) 5.7 (1.5) 0.19 
SD=standard deviation; CI=confidence interval; HDL=high-density lipoprotein; LDL=low-density lipoprotein; GGT=gamma-glutamyltransferase; 
ALT= alanine transaminase; AST=aspartate transaminase 
  
Table 2. Percent of the association of body mass index (BMI, kg/m
2
) and waist circumference (WC, cm) with fasting glucose (mmol/l) mediated 
by gamma-glutamyltransferase(GGT, u/l), alanine transaminase (ALT, u/l) and aspartate transaminase (AST, u/l) 
 
Exposures 
(E) 
Mediators 
(M) 
Average causal mediated 
effect 
Non-mediated 
effect 
Total effect % of total effect mediated P for E-M 
interaction 
β-coefficient (95% CI) † β-coefficient (95% 
CI)
 †
 
β-coefficient (95% 
CI)
 †
 
% (95% CI) 
Women        
BMI GGT 0.05 (0.04 to 0.07) 0.13 (0.09 to 0.17) 0.18 (0.15 to 0.22) 30% (23% to 40%) 0.03 
BMI ALT 0.03 (0.03 to 0.04) 0.15 (0.11 to 0.19) 0.19 (0.15 to 0.23) 15% (14% to 25%) <0.001 
BMI 
AST 
0.0001 (-0.0012 to 
0.0015) 
0.18 (0.14 to 0.21) 0.18 (0.14 to 0.21) 0.01% (-0.70% to 0.79%) 
0.99 
WC GGT 0.08 (0.06 to 0.10) 0.20 (0.16 to 0.24) 0.28 (0.23 to 0.32) 28% (23% to 34%) <0.001 
WC ALT 0.04 (0.03 to 0.05) 0.22 (0.18 to 0.26) 0.26 (0.22 to 0.30) 14% (10% to 18%) <0.001 
WC AST -0.001 (-0.003 to 0.0003) 0.24 (0.21 to 0.28) 0.24 (0.20 to 0.28) -0.03% (-1.2% to 0.1%) 0.33 
Men        
BMI GGT 0.04 (0.02 to 0.06) 0.21 (0.14 to 0.28) 0.25 (0.18 to 0.32) 16% (9% to 26%) 0.14 
BMI ALT 0.03 (0.01 to 0.05) 0.23 (0.16 to 0.30) 0.26 (0.20 to 0.33) 12% (4% to 22%) <0.001 
BMI AST -0.0002 (-0.004 to 0.003) 0.25 (0.18 to 0.32) 0.25 (0.19 to 0.32) -0.04% (-1.6% to 1.3%) 0.87 
WC GGT 0.05 (0.03 to 0.06) 0.16 (0.10 to 0.22) 0.20 (0.14 to 0.26) 23% (12% to 36%) 0.49 
WC ALT 0.02 (0.01 to 0.04) 0.18 (0.12 to 0.24) 0.20 (0.14 to 0.26) 12% (4% to 22%) 0.61 
WC AST 0.0006 (-0.002 to 0.004) 0.20 (0.14 to 0.26) 0.20 (0.14 to 0.26) 0.2% (-1.1% to 1.9%) 0.92 
†
: Adjusted for age, sex, education, physical activity, alcohol use and smoking.  
*: All mediators or risk factors were standardized using Z-scores to facilitate comparison and interpretation. 
 
 
 
 
